Leo International Precision Health AG (“LIPH”) is a Frankfurt Stock Exchangelisted investment holding company building a global integrated AI-driven healthcare ecosystem. With a strategic focus on AI-driven precision healthcare, the company invests in assets across Biotech, MedTech, HealthTech and Healthcare Services. Through its portfolio, LIPH  offers investors access to the expanding Asian and global healthcare and life sciences market.
The company formerly operated under the name SPOBAG AG. As part of a change of control, the company changed its business focus, strategy and branding in 2025.

Capital under management
• Portfolio valuation: approx. EUR 109 million after recent acquisitions
• Share capital: EUR 550,000

Industry focus
Core sectors:
• Biotech
• Medtech
• HealthTech
• Healthcare Services
• Artifi cial intelligence in healthcare
• Precision health

Portfolio and exits
• Acquisition of 6 portfolio companies via contributions in kind
• Planned acquisition of up to 20 companies globally

Stock information
• Ticker symbol: LEOW
• ISIN / WKN: DE0005490601 / 549060
• Segment: General Standard
• Shares outstanding: 550,000

Date of foundation
Founded: 1999 (registered in 2000)

Contact information

Address: Am Klopferspitz 19 | 82152 Planegg/ Martinsried
Web Address: www.liphag.com